Leyden Labs logo

Leyden Labs

Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families. The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

http://leydenlabs.com
51-200 employees
Leyden Labs logo

Leyden Labs

Leyden Labs develops intranasal antibody sprays for broad protection against respiratory viruses, targeting the general population and institutions preparing for pandemics.

Company Size

51-200 employees

Location

Netherlands

About

Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families. The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

Needs Assessment

Active buying signals and potential business opportunities

Technology Requirements

Intranasal formulation & device technologies

Webhosting

Mail and office software

Data analytics

Service Requirements

Autonomous protection through accessible and self-administrable products

Data protection and privacy compliance (GDPR)

Clinical development services to advance product candidates

Service and support engineers

Infrastructure Requirements

Secure web communication (SSL certificates)

Data backup technology

Physical/digital access control mechanisms

AI Insights

Growth Trajectory

With $70M raised and Leyden Labs Asia Pte. Ltd. established in Singapore, the company indicates strong growth potential through advancing its intranasal antibody programs and expanding its market reach.

Market Opportunity

Leyden Labs has a strong market opportunity in addressing the need for preventative medicines against respiratory viruses, particularly by providing broad, universal protection and easy self-administration.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats